![The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells | Science Translational Medicine The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.aau5907/asset/61cfb3c1-c89e-4dc6-8bd5-9576f01d64aa/assets/graphic/aau5907-f1.jpeg)
The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells | Science Translational Medicine
![CD19/CD22 Chimeric Antigen Receptor T Cell Cocktail Therapy following Autologous Transplantation in Patients with Relapsed/Refractory Aggressive B Cell Lymphomas - Transplantation and Cellular Therapy, Official Publication of the American Society for ... CD19/CD22 Chimeric Antigen Receptor T Cell Cocktail Therapy following Autologous Transplantation in Patients with Relapsed/Refractory Aggressive B Cell Lymphomas - Transplantation and Cellular Therapy, Official Publication of the American Society for ...](https://www.astctjournal.org/cms/asset/98b91948-9c25-4463-ae3c-76206f632651/gr1.jpg)
CD19/CD22 Chimeric Antigen Receptor T Cell Cocktail Therapy following Autologous Transplantation in Patients with Relapsed/Refractory Aggressive B Cell Lymphomas - Transplantation and Cellular Therapy, Official Publication of the American Society for ...
![Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome | Science Immunology Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.aax7969/asset/1d238184-4fc6-4c42-8ec4-964e745e9ca6/assets/graphic/aax7969-f1.jpeg)
Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome | Science Immunology
![Genes | Free Full-Text | Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers Genes | Free Full-Text | Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers](https://pub.mdpi-res.com/genes/genes-12-00616/article_deploy/html/images/genes-12-00616-g001.png?1619007337)
Genes | Free Full-Text | Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers
![Frontiers | Overexpression of Interferon-Inducible Protein 16 Promotes Progression of Human Pancreatic Adenocarcinoma Through Interleukin-1β-Induced Tumor-Associated Macrophage Infiltration in the Tumor Microenvironment Frontiers | Overexpression of Interferon-Inducible Protein 16 Promotes Progression of Human Pancreatic Adenocarcinoma Through Interleukin-1β-Induced Tumor-Associated Macrophage Infiltration in the Tumor Microenvironment](https://www.frontiersin.org/files/Articles/640786/fcell-09-640786-HTML/image_m/fcell-09-640786-g001.jpg)
Frontiers | Overexpression of Interferon-Inducible Protein 16 Promotes Progression of Human Pancreatic Adenocarcinoma Through Interleukin-1β-Induced Tumor-Associated Macrophage Infiltration in the Tumor Microenvironment
![Frontiers | Therapeutic Potential of TNFα and IL1β Blockade for CRS/ICANS in CAR-T Therapy via Ameliorating Endothelial Activation Frontiers | Therapeutic Potential of TNFα and IL1β Blockade for CRS/ICANS in CAR-T Therapy via Ameliorating Endothelial Activation](https://www.frontiersin.org/files/Articles/623610/fimmu-12-623610-HTML/image_m/fimmu-12-623610-g001.jpg)
Frontiers | Therapeutic Potential of TNFα and IL1β Blockade for CRS/ICANS in CAR-T Therapy via Ameliorating Endothelial Activation
![Generation of recombinant hyperimmune globulins from diverse B-cell repertoires | Nature Biotechnology Generation of recombinant hyperimmune globulins from diverse B-cell repertoires | Nature Biotechnology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41587-021-00894-8/MediaObjects/41587_2021_894_Fig1_HTML.png)
Generation of recombinant hyperimmune globulins from diverse B-cell repertoires | Nature Biotechnology
![Diseases | Free Full-Text | Cardiotoxicity Associated with Anti-CD19 Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Recognition, Risk Factors, and Management Diseases | Free Full-Text | Cardiotoxicity Associated with Anti-CD19 Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Recognition, Risk Factors, and Management](https://www.mdpi.com/diseases/diseases-09-00020/article_deploy/html/images/diseases-09-00020-g001.png)